BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30393842)

  • 21. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
    Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
    J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.
    Raspagliesi F; Maltese G; Bogani G; Fucà G; Lepori S; De Iaco P; Perrone M; Scambia G; Cormio G; Bogliolo S; Bergamini A; Bifulco G; Casali PG; Lorusso D
    Gynecol Oncol; 2017 Jan; 144(1):90-95. PubMed ID: 27817933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidental power morcellation of malignancy: a retrospective cohort study.
    Graebe K; Garcia-Soto A; Aziz M; Valarezo V; Heller PB; Tchabo N; Tobias DH; Salamon C; Ramieri J; Dise C; Slomovitz BM
    Gynecol Oncol; 2015 Feb; 136(2):274-7. PubMed ID: 25740603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of occult uterine leiomyosarcoma after surgery for presumed uterine fibroids: a systematic review.
    Pritts EA; Parker WH; Brown J; Olive DL
    J Minim Invasive Gynecol; 2015 Jan; 22(1):26-33. PubMed ID: 25193444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.
    Xu X; Lin H; Wright JD; Gross CP; Boscoe FP; Hutchison LM; Schwartz PE; Desai VB
    J Clin Oncol; 2019 Dec; 37(35):3412-3424. PubMed ID: 31518176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey among ESGE members on leiomyosarcoma morcellation incidence.
    Tanos V; Brölmann H; DeWilde RL; O'Donovan P; Symeonidou E; Campo R
    Gynecol Surg; 2017; 14(1):25. PubMed ID: 29238287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
    Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
    J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive-age women.
    Pados G; Tsolakidis D; Theodoulidis V; Makedos A; Zaramboukas T; Tarlatzis B
    Hum Reprod; 2017 Oct; 32(10):2036-2041. PubMed ID: 28938732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI Evaluation of Uterine Masses for Risk of Leiomyosarcoma: A Consensus Statement.
    Hindman N; Kang S; Fournier L; Lakhman Y; Nougaret S; Reinhold C; Sadowski E; Huang JQ; Ascher S
    Radiology; 2023 Feb; 306(2):e211658. PubMed ID: 36194109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic myomectomy and morcellation: A review of techniques, outcomes, and practice guidelines.
    Glaser LM; Friedman J; Tsai S; Chaudhari A; Milad M
    Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():99-112. PubMed ID: 29078975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indications for morcellation in gynecologic surgery.
    Parker WH
    Curr Opin Obstet Gynecol; 2018 Feb; 30(1):75-80. PubMed ID: 29251677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
    Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
    Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation.
    Ricci S; Stone RL; Fader AN
    Gynecol Oncol; 2017 Apr; 145(1):208-216. PubMed ID: 28209496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy.
    Zhang J; Zhang J; Dai Y; Zhu L; Lang J; Leng J
    Int J Gynaecol Obstet; 2015 Aug; 130(2):195-9. PubMed ID: 26117552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of unexpected uterine leiomyosarcoma during laparoscopic procedures: Experience from a single tertiary institute in Italy.
    Surace A; Baù MG; Privitera S; Botta G; Danese S; Plazzotta C; Mitidieri M; Picardo E
    Int J Gynaecol Obstet; 2022 Feb; 156(2):236-239. PubMed ID: 33834486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic Myomectomy: A Single-center Retrospective Review of 514 Patients.
    Bean EM; Cutner A; Holland T; Vashisht A; Jurkovic D; Saridogan E
    J Minim Invasive Gynecol; 2017; 24(3):485-493. PubMed ID: 28104498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of unexpected leiomyosarcoma in a Turkish province: a retrospective multi-centre study in a low income setting.
    Taşdemir Ü; Ceran MU; Önder Dirican A; Akar S; Çelik Ç; Energin H; Görkemli H; Mammadova N; Çolak E; Ayhan A
    J Obstet Gynaecol; 2022 Aug; 42(6):2208-2212. PubMed ID: 35253591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.
    Rutstein SE; Siedhoff MT; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL; Wheeler SB
    J Minim Invasive Gynecol; 2016 Feb; 23(2):223-33. PubMed ID: 26475764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morcellation and myomas: Balancing decisions around minimally invasive treatments for fibroids.
    Siedhoff MT; Kim KH
    J Surg Oncol; 2015 Dec; 112(7):769-71. PubMed ID: 26768314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Power morcellation-induced dissemination of sarcomatous component arising in leiomyoma.
    Emoto I; Moriuchi K; Kanbayashi S; Inohaya A; Ri Y; Sato Y
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1843-1849. PubMed ID: 29974551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.